Opportunity Information: Apply for PA 16 240
Apply for PA 16 240
- The HHS-NIH11 in the health sector is offering a public funding opportunity titled "Mechanisms Mediating Osteoarthritis in Aging (R21)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.866,.
- This funding opportunity was created on May 09, 2016 and posted on May 09, 2016.
- Applicants must submit their applications by Sep 07, 2019. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For profit organizations other than small businesses, Small businesses, Others (see text field entitled Additional Information on Eligibility for clarification).
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The grant opportunity "Mechanisms Mediating Osteoarthritis in Aging (R21)" (Funding Opportunity Number PA-16-240) is an NIH exploratory/developmental research call aimed at speeding up early-stage, high-impact work on osteoarthritis (OA), with a specific emphasis on how aging influences the disease. The core intent is to fund projects that can open up new ways of thinking about OA by testing fresh hypotheses and building or validating new experimental paradigms that improve understanding of how OA starts and how it worsens over time. Rather than focusing on incremental advances, the announcement is set up to encourage projects that are still in their conceptual or formative phases, where the key contribution may be a novel idea, a proof of concept, or an enabling approach that positions the field for larger-scale studies later.
Because it uses the NIH R21 mechanism, the program is designed for exploratory and developmental research, meaning applicants are expected to take on questions where the path is not fully mapped out and where the work may carry substantial scientific risk. That risk is considered acceptable because the payoff could be substantial: identifying previously unrecognized biological pathways involved in OA initiation or progression, clarifying how aging-related processes shape joint degeneration, or generating new tools that make it possible to ask better questions in future studies. The FOA explicitly supports work that could lead to breakthroughs or to the creation of novel techniques, agents, methodologies, models, or applications with the potential to shift how OA research is conducted.
In practical terms, the opportunity is centered on mechanism-focused research tied to aging and OA. Projects responsive to the announcement would typically aim to explain causality and biological mediation, for example by characterizing molecular, cellular, tissue-level, biomechanical, or systemic factors that link aging biology to cartilage breakdown, synovial inflammation, subchondral bone changes, impaired repair processes, or other features of OA pathology. The emphasis on "new paradigms" signals interest in studies that challenge prevailing assumptions or introduce new experimental frameworks, such as innovative model systems, emerging measurement approaches, or integrative strategies that reveal how age-related changes interact with joint injury, inflammation, metabolism, or mechanical stress.
The announcement is offered by the U.S. Department of Health and Human Services through the National Institutes of Health (Agency listed as HHS-NIH11) and is categorized as a discretionary grant in the health domain, associated with CFDA numbers 93.866 (and also listed with 93.866 in the source). Eligibility is broad and includes many types of applicants: state, county, city, and special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments and other tribal organizations; public housing authorities/Indian housing authorities; nonprofit organizations with or without 501(c)(3) status (excluding higher education institutions in those categories as specified); for-profit organizations other than small businesses; and small businesses, along with other entities as clarified in the FOA's additional eligibility information. This wide eligibility reflects NIH's interest in drawing in diverse research environments and multidisciplinary teams capable of advancing aging-related OA mechanisms.
Key administrative details from the posting indicate it was created and posted on May 9, 2016, with an original and current closing date of September 7, 2019. The source data does not specify an award ceiling or expected number of awards in the provided fields, which suggests those details would need to be confirmed in the full FOA text or NIH guidance for that cycle. Overall, the opportunity is best understood as a catalyst program: it is meant to help investigators move promising, potentially field-changing ideas from early concept to a point where they are sufficiently characterized, demonstrated, or tooled-up to justify larger, more definitive studies on how aging drives the onset and progression of osteoarthritis.
Frequently Asked Questions (FAQs): Mechanisms Mediating Osteoarthritis in Aging (R21) - PA-16-240
What is the name of this grant opportunity?
The opportunity is titled "Mechanisms Mediating Osteoarthritis in Aging (R21)" and is associated with Funding Opportunity Number (FON) PA-16-240.
Which agency is offering this funding opportunity?
This funding opportunity is offered by the U.S. Department of Health and Human Services (HHS) through the National Institutes of Health (NIH). The agency is listed as HHS-NIH11.
What kind of grant mechanism is this (and what does R21 mean)?
This opportunity uses the NIH R21 mechanism, which is intended for exploratory and developmental research. In practice, that means it is designed to support early-stage, high-impact projects where the approach may be less mature, the path to results may not be fully mapped out, and the work may involve substantial scientific risk.
What is the overall purpose of this FOA?
The FOA is intended to accelerate early-stage, potentially high-impact research on osteoarthritis (OA), with a specific emphasis on understanding how aging influences OA. The goal is to fund projects that can open up new ways of thinking about OA by testing fresh hypotheses and by developing or validating new experimental paradigms that improve understanding of how OA begins and how it worsens over time.
Is this opportunity meant for incremental research or more novel/high-risk ideas?
This opportunity is explicitly positioned to encourage projects that are still in conceptual or formative phases and that can introduce novel ideas, proofs of concept, or enabling approaches. It is not framed as a program for incremental advances; instead, it supports research risk when the potential payoff could be substantial.
What scientific topic area does this grant focus on?
The focus is on mechanisms mediating osteoarthritis in the context of aging. The opportunity emphasizes mechanistic, causality-oriented research that links aging biology to OA initiation and progression.
What kinds of research questions are considered responsive to this announcement?
Projects are expected to be mechanism-focused and tied to aging and OA. Responsive studies would typically aim to explain causality and biological mediation by characterizing molecular, cellular, tissue-level, biomechanical, or systemic factors that connect aging-related processes to OA pathology.
What OA-related disease features are mentioned as examples of relevant focus areas?
The description highlights examples such as cartilage breakdown, synovial inflammation, subchondral bone changes, and impaired repair processes, as well as other features of OA pathology that may be influenced by aging.
What does the FOA mean by "new paradigms"?
Based on the description provided, "new paradigms" signals interest in studies that challenge prevailing assumptions or introduce new experimental frameworks. Examples mentioned include innovative model systems, emerging measurement approaches, or integrative strategies that reveal how age-related changes interact with factors like joint injury, inflammation, metabolism, or mechanical stress.
Does this FOA support tool or method development?
Yes. The FOA explicitly supports work that could lead to breakthroughs or the creation of novel techniques, agents, methodologies, models, or applications that could shift how OA research is conducted and enable stronger future studies.
Why does the FOA emphasize "exploratory/developmental" research?
The R21 structure is meant for projects where uncertainty and risk are acceptable because the potential payoff could be high. The FOA is described as a catalyst program that can help move field-changing ideas from early concept to a more demonstrated or validated state suitable for larger studies later.
What kinds of outcomes or contributions is this FOA aiming to generate?
The FOA aims to generate outcomes such as identifying previously unrecognized biological pathways involved in OA initiation or progression, clarifying how aging-related processes shape joint degeneration, and developing new tools or experimental paradigms that improve what researchers can ask and test in subsequent, larger-scale studies.
Who is eligible to apply?
Eligibility is described as broad. Eligible applicants include state, county, city, and special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments and other tribal organizations; public housing authorities/Indian housing authorities; nonprofit organizations with or without 501(c)(3) status (excluding higher education institutions in those categories as specified); for-profit organizations other than small businesses; and small businesses, along with other entities as clarified in the FOA's additional eligibility information.
Is this opportunity limited to academic institutions?
No. While institutions of higher education are included, the eligibility list also includes multiple government entities, nonprofits, for-profit organizations (other than small businesses), and small businesses, as well as tribal governments and tribal organizations.
What is the grant category/type in the posting?
The posting categorizes this as a discretionary grant in the health domain.
What CFDA number is associated with this opportunity?
The opportunity is associated with CFDA number 93.866 (and the source also lists 93.866).
When was the posting created and posted?
The posting indicates it was created and posted on May 9, 2016.
What is the closing date for this opportunity?
The posting lists an original closing date of September 7, 2019, and the current closing date is also shown as September 7, 2019.
Is the award ceiling listed in the provided information?
No. The source data provided does not specify an award ceiling in the relevant fields. Based on the information provided here, award size would need to be confirmed in the full FOA text or NIH guidance for the applicable cycle.
Is the expected number of awards listed in the provided information?
No. The source data provided does not specify an expected number of awards. That detail would need to be confirmed in the full FOA text or NIH guidance for that cycle.
What stage of research is this opportunity best suited for?
It is best suited for early-stage work where the key contribution may be a novel hypothesis, proof of concept, validation of a new experimental paradigm, or development of enabling approaches that position the field for larger, more definitive studies later.
Does the FOA encourage multidisciplinary approaches?
While the FOA text provided does not prescribe specific disciplines, it emphasizes drawing in diverse research environments and multidisciplinary teams capable of advancing understanding of aging-related OA mechanisms.
Browse more opportunities from the same category: Health
Next opportunity: Behavioral Health Workforce Education and Training (BHWET) for Paraprofessionals and Professionals
Previous opportunity: DoD Neurofibromatosis New Investigator Award
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PA 16 240
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (PA 16 240) also looked into and applied for these:
| Funding Opportunity |
|---|
| Behavioral Health Workforce Education and Training (BHWET) for Paraprofessionals and Professionals Apply for HRSA 16 193 Funding Number: HRSA 16 193 Agency: HHS-HRSA Category: Health Funding Amount: Case Dependent |
| Limited Competition: NIGMS Mature Synchrotron Resources for Structural Biology (P30) Apply for PAR 16 247 Funding Number: PAR 16 247 Agency: HHS-NIH11 Category: Health Funding Amount: Case Dependent |
| Limited Competition: Renewal of Centers of Biomedical Research Excellence (COBRE)(P20) Apply for PAR 16 241 Funding Number: PAR 16 241 Agency: HHS-NIH11 Category: Health Funding Amount: $1,500,000 |
| Mechanisms Mediating Osteoarthritis in Aging (R01) Apply for PA 16 239 Funding Number: PA 16 239 Agency: HHS-NIH11 Category: Health Funding Amount: Case Dependent |
| Impact of Aging in Human Cell Models of Alzheimer's Disease (R01) Apply for RFA AG 17 009 Funding Number: RFA AG 17 009 Agency: HHS-NIH11 Category: Health Funding Amount: $250,000 |
| Specialized Alcohol Research Centers (P50) Apply for RFA AA 17 001 Funding Number: RFA AA 17 001 Agency: HHS-NIH11 Category: Health Funding Amount: $1,150,000 |
| Novel Approaches to Understanding, Preventing and Treating Lyme Disease and Tick-borne Coinfections (R01) Apply for PA 16 243 Funding Number: PA 16 243 Agency: HHS-NIH11 Category: Health Funding Amount: Case Dependent |
| Nathan Shock Centers Coordinating Center (U24) Apply for RFA AG 17 008 Funding Number: RFA AG 17 008 Agency: HHS-NIH11 Category: Health Funding Amount: $350,000 |
| Informatics Methodology and Secondary Analyses to Explore Shared Immunology Study Data in ImmPort (UH2) Apply for PAR 16 253 Funding Number: PAR 16 253 Agency: HHS-NIH11 Category: Health Funding Amount: $200,000 |
| Ryan White HIV/AIDS Program Building Care and Prevention Capacity: Addressing the HIV Care Continuum in Southern Metropolitan Areas Apply for HRSA 16 187 Funding Number: HRSA 16 187 Agency: HHS-HRSA Category: Health Funding Amount: Case Dependent |
| From Association to Function in the Alzheimers Disease Post Genomics Era (R21) Apply for RFA AG 17 011 Funding Number: RFA AG 17 011 Agency: HHS-NIH11 Category: Health Funding Amount: $200,000 |
| Centers of Research Translation (CORT) (P50) Apply for RFA AR 17 001 Funding Number: RFA AR 17 001 Agency: HHS-NIH11 Category: Health Funding Amount: $1,000,000 |
| Mechanisms of Mycobacterial-Induced Immunity in HIV-Infected and Uninfected Individuals to Inform Tuberculosis Vaccine Design (R01) Apply for PAR 16 254 Funding Number: PAR 16 254 Agency: HHS-NIH11 Category: Health Funding Amount: Case Dependent |
| Mississippi Delta Health Collaborative Apply for CDC RFA DP16 1612 Funding Number: CDC RFA DP16 1612 Agency: HHS-CDC-NCCDPHP Category: Health Funding Amount: $3,150,000 |
| Public Health Preparedness and Response (PHPR) Cooperative Agreement for All-Hazards Public Health Emergencies: Zika 2016 Apply for CDC RFA TP16 1602 Funding Number: CDC RFA TP16 1602 Agency: HHS-CDC-OPHPR Category: Health Funding Amount: $5,000,000 |
| Grants for Early Medical/Surgical Subspecialists' Transition to Aging Research (GEMSSTAR) (R03) Apply for RFA AG 17 012 Funding Number: RFA AG 17 012 Agency: HHS-NIH11 Category: Health Funding Amount: $75,000 |
| From Association to Function in the Alzheimers Disease Post Genomics Era (R01) Apply for RFA AG 17 010 Funding Number: RFA AG 17 010 Agency: HHS-NIH11 Category: Health Funding Amount: $350,000 |
| Establishment of Centers of Excellence in Refugee Health Apply for CDC RFA CK15 150302CONT16 Funding Number: CDC RFA CK15 150302CONT16 Agency: HHS-CDC-NCEZID Category: Health Funding Amount: Case Dependent |
| Learning Collaboratives for Advanced Business Acumen Skills Apply for HHS 2016 ACL CIP PPBA 0181 Funding Number: HHS 2016 ACL CIP PPBA 0181 Agency: HHS-ACL Category: Health Funding Amount: $500,000 |
| Creutzfeldt - Jakob Disease (CJD) Support, Education, and Awareness Projects as Apply for CDC RFA CK15 150402CONT16 Funding Number: CDC RFA CK15 150402CONT16 Agency: HHS-CDC-NCEZID Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants

Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PA 16 240", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
